Vectorized Anti-Tnf-Alpha Inhibitors For Ocular Indications - EP4518973
The patent EP4518973 was granted to Regenxbio on Mar 12, 2025. The application was originally filed on May 3, 2023 under application number EP23730320A. The patent is currently recorded with a legal status of "Request For Examination Was Made".
EP4518973
- Application Number
- EP23730320A
- Filing Date
- May 3, 2023
- Status
- Request For Examination Was Made
- Feb 7, 2025
- Publication Date
- Mar 12, 2025
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents